P. Connor Johnson
ORCID: 0000-0002-3943-6608Also affiliated with Massachusetts General Hospital, Center for Cancer Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation”.
Jacob Soumerai, Jeremy S. Abramson, Jeffrey A. Barnes, Philip Caron, Shalini Chhabra +23 more
Jennifer A. Woyach, Angela K. Ulrich, Veronique Marcotte, Ryan David Nipp, Daniel E. Lage +17 more
Thomas Jedidiah Jenks Doman, Zoe Antenucci, John Efromson, P. Connor Johnson, Michael T. Simonich +4 more
Matthew Lei, Robert Redd, Ruchi Rana, Uvette Lou, Mark N Sorial +19 more
Tejaswini Dhawale, Richard Newcomb, Hermioni L. Amonoo, Ashley M. Nelson, Daniel Yang +7 more
P. Connor Johnson, Haesook T. Kim, Alisha Yi, Meghan E. Sise, David E. Leaf +14 more
Monica H. Bodd, Matthew Reynolds, Ashley M. Nelson, Richard Newcomb, P. Connor Johnson +13 more